Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Toxic Effect of Latex, Accidental (Unintentional), Subsequent Encounter (ICD-10-CM Code: T65.811D)
Summary
This condition describes adverse health effects resulting from unintentional exposure to latex, with "subsequent encounter" indicating the patient is receiving follow-up care after an initial treatment for the toxic effect. It encompasses reactions caused by accidental contact with latex-containing products, where exposure was not deliberate.
Causes
The toxic effect arises from accidental contact with latex, which can occur through direct skin contact, inhalation of airborne particles, or mucosal exposure. Common sources include medical gloves, balloons, condoms, or other latex-based items. The "subsequent encounter" modifier applies when the patient returns for ongoing management of the condition.
Risk Factors
- Frequent use of latex products in occupational settings (e.g., healthcare, manufacturing).
- History of latex allergy or sensitivity.
- Repeated exposure to latex in environments with poor ventilation.
- Underlying atopic conditions (e.g., asthma, eczema).
Symptoms
- Skin reactions: itching, redness, hives, or contact dermatitis.
- Respiratory symptoms: sneezing, coughing, wheezing, or asthma exacerbation.
- Mucosal irritation: nasal congestion, eye redness, or throat discomfort.
- Severe reactions: anaphylaxis (rare but possible with high exposure).
Diagnosis
Diagnosis relies on clinical assessment, patient history of exposure, and correlation with symptoms. Skin prick tests or blood tests for latex-specific IgE may confirm sensitivity. The "subsequent encounter" modifier is used when the patient is receiving follow-up care for the condition.
Treatment Options
Treatment focuses on managing ongoing symptoms and preventing further exposure. This may include topical corticosteroids for skin reactions, bronchodilators for respiratory symptoms, and antihistamines for mild allergic responses. Long-term management often involves avoiding latex-containing products.
Prognosis and Follow-Up
Prognosis depends on the severity of the initial reaction and adherence to avoidance measures. Follow-up care aims to monitor for recurrence, adjust treatment as needed, and educate the patient on latex avoidance. Most patients improve with proper management, but severe reactions may require ongoing monitoring.
Complications
- Chronic dermatitis or skin sensitivity.
- Persistent respiratory issues (e.g., asthma).
- Anaphylactic reactions with re-exposure.
- Occupational or lifestyle limitations due to latex avoidance.
Lifestyle & Prevention
- Avoid latex-containing products (e.g., gloves, balloons, condoms).
- Use alternative materials (e.g., nitrile, vinyl) when possible.
- Inform healthcare providers of latex allergy to ensure safe care.
- Maintain a latex-free environment at home and work.
When to Seek Professional Help
Seek immediate medical attention if symptoms worsen, new symptoms develop, or severe reactions (e.g., difficulty breathing, swelling) occur. Follow-up with a healthcare provider if symptoms persist or re-exposure is suspected.
Tips for Medical Coders
Use T65.811D for subsequent encounters related to accidental latex exposure. Document the patient's history of exposure, current symptoms, and ongoing management to support the "subsequent encounter" modifier. Ensure the encounter is not the initial treatment for the toxic effect.
T65.811D policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.